Expert Panel of Central Drug Regulatory Authority Recommends Market Authorisation for ... - Latest Tweet by PTI News

The latest Tweet by PTI News states, 'Expert panel of central drug regulatory authority recommends market authorisation for Serum Institute of India's Covid vaccine Covovax as heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin: Official sources'

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

Share Now